The Discounted Cash Flow (DCF) valuation of Jazz Pharmaceuticals PLC (JAZZ) is 195.11 USD. With the latest stock price at 111.57 USD, the upside of Jazz Pharmaceuticals PLC based on DCF is 74.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.9% | 6.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 75.47 - 2,341.99 | 195.11 |
| Upside | -32.4% - 1999.1% | 74.9% |